RETRACTED: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1

Huixing Deng, Geng Qianqian, Ji Ting, Yang Aimin

Open source

DOI
10.1016/j.biopha.2018.07.024
Published
2018-10
Container
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

serious concern Score 11/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2018.07.024,
  title = {RETRACTED: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1},
  author = {Huixing Deng and Geng Qianqian and Ji Ting and Yang Aimin},
  year = {2018},
  journal = {Biomedicine \& Pharmacotherapy},
  doi = {10.1016/j.biopha.2018.07.024},
  url = {https://doi.org/10.1016/j.biopha.2018.07.024}
}

RIS

TY  - JOUR
TI  - RETRACTED: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1
AU  - Huixing Deng
AU  - Geng Qianqian
AU  - Ji Ting
AU  - Yang Aimin
PY  - 2018
JO  - Biomedicine & Pharmacotherapy
DO  - 10.1016/j.biopha.2018.07.024
UR  - https://doi.org/10.1016/j.biopha.2018.07.024
ER  - 

APA

Deng, H., Qianqian, G., Ting, J., & Aimin, Y. (2018). RETRACTED: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2018.07.024

Source records